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1. Introduction 
Animals with experimental lergic encephalo- 
myelitis (EAE), an autoimmune demyelinating 
disease induced by injection of whole central nervous 
system (CNS) homogenate, show preferential changes 
of the glycosphingolipid (cerebroside and sulphatide) 
content and increased amounts of esterified choles- 
terol in the CNS [ 1,2] . By studying the CNS lipid 
composition of animals injected with purified con- 
stituents of myelin we were able to identify the CNS 
components which separately induced some of the 
above alterations. Thus, the encephalitogenic basic 
protein of myelin induced the classical neurological 
symptoms of EAE [3] together with alterations in 
the content of CNS sulphatides but no change in the 
content of cerebrosides oresterified cholesterol 
[2,4]. Changes in the level of cerebrosides were only 
induced when animals were sensitized with mixtures 
containing CNS lipids [2,4] . Also, since lipid altera- 
tions were induced in animals injected with non- 
encephalitogenic preparations a dissociation between 
paralysis and lipid changes was established [4] . 
However, none of the purified CNS components so 
far injected were able to induce the appearance of
increased amounts of esterified cholesterol which, 
Part of this work was presented at the International Sym- 
posium on Function and Biosynthesis of Lipids, 1976, Sierra 
de la Ventana, Buenos Aires, Argentina 
apart from occurring in EAE, is also a characteristic 
alteration of several human demyelinating diseases 
[5] . We will present here evidence indicating that 
the purified apoprotein of Folch’s proteolipid can 
induce alterations in the level of esterified cholesterol. 
In addition, a hypothesis that explains the different 
lipid alterations on the basis of disturbed molecular 
interactions in the myelin membrane isproposed. 
2. Materials and methods 
Rats 50-60 day old were used. Freund’s complete 
adjuvant was prepared with lanolin in paraffin oil 
(lo%, w/v) containing 2mg/ml of heat-killed 
Mycobacterium tuberculosis (BCG D(ierr, Bs. As., 
Argentina). Crude myelin was prepared from white 
matter of beef brain as in [6] and lyophilized. Puri- 
tied apoprotein of Folch’s proteolipid was obtained 
from bovine brain white matter as in [7] and rendered 
soluble in water [8]. Preparation of myelin basic 
protein from bovine spinal cord, CNS lipids, and 
quantitative determinations have been described [2] . 
The identification of the cholesterol moiety of the 
sterol esters by gas-liquid chromatography (GLC) 
was done essentially as reported [l] . Details of the 
injection procedures are given under table 1. All 
animals were killed by decapitation when neurological 
signs of EAE were present in animals injected with 
encephalitogenic preparations (lo-13 days after 
injections). 
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3. Results and discussion 
Animals sensitized with apoprotein of Folch’s 
proteolipid which showed no paralytic symptoms had 
an increased amount of esterified cholesterol in 
brain (fig.1); after saponification, the sterol portion 
of the ester was further identified as cholesterol by 
both thin-layer chromatography (TLC) and GLC. The 
injection of CNS white matter homogenates ora 
myelin preparation, both of which contain the Folch’s 
proteolipid as a constituent, also induced a similar 
increase. The amount of sterol esters in normal adult 
rat brain is below 0.1% of the free cholesterol fraction 
[9] and the increase observed in animals ensitized 
with the apoprotein of Folch’s proteolipid amounted 
approximately to thirty times that quantity, as esti- 
mated by GLC by comparison with a known amount 
of standard. Besides, the injection of the purified 
St FC WM My AFP BP BPL St 
Fig.1. TLC of brain cholesterol esters. Esterifled cholesterol 
was purified from a lower phase aliquot of Folch’s partition, 
corresponding to 0.1 g tissue as in [23]. After running with 
heptane-ethyl ether (24 : 1) spots were visualized with 
Liebermann-Bouchard reagent. St, standard of cholesterol 
oleate. FC, WM, My, AFP, BP or BPL represent materials 
from animals of the different groups defined in table 1. A 
similar pattern was found for spinal cord. 
Fig.2. Possible mechanisms leading to selective lipid altera- 
tions in EAE. (I) Simplified structure of part of a normal 
myelin membrane [131. The myelin basic protein (BP) and 
apoprotein of Folch’s proteolipid (AFP) are shown interact- 
ing preferentially with sulphatides (o) and with cholesterol 
(e), respectively. (II) Modified membrane a:fter interaction 
with a sensitized cell (SC) removing BP with associated 
sulphatides. (III) Only AFP is being removed by the SC leaving 
cholesterol available for alteration. (IV) Interactions of cere- 
brosides (0) with other membrane components have been 
disturbed by a humoral antibody (Ab). 
apoprotein induced a significant alteration in the ievel 
of brain total cholesterol and sulphatides (table 1). 
We do not have a clear explanation at present of the 
cholesterol decrease induced by the Folch’s apo- 
protein, which was not observed in the spinal cord. 
The metabolism of cholesterol in the CNS is not 
thoroughly known, however, lithocholic acid has 
been found in the brain of EAE animals and it has 
been proposed that cholesterol degradation could 
have been the source of this metabolite which is 
rapidly expelled from the brain [ 10 ] . As found in 
guinea pigs [2] , neither purified myelin basic protein 
nor a mixture of it with CNS lipids induced the 
appearance of detectable amounts of esterified choles- 
terol and the changes for sulphatides were similar to 
those reported [2,4] . Our data have been obtained 
analyzing the whole brain; nevertheless, the changes 
described will be interpreted on the basis of a modi- 
fied myelin membrane structure since both, the 
altered lipids and the purified components injected 
are major constituents of myelin [3,&l 11 .
The changes in the lipid content induced by the 
purified apoprotein of Folch’s proteolipid give further 
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Table 1 
February 1978 
Brain lipid content of rats sensitized to different CNS components 
Animals 
injected with 
Freund’s complete 
adjuvant 
Sulphatides Total cholesterol Total phospholipids 
(q/g w.w.1 (mg/g w.w.) (pmol lipid P/g w.w.) 
(FC) (8) 4.26 i 0.24 22.9 f 0.9 70.3 f 2.2 
Percentage differences with respect to animals FC 
White matter 
Myelin 
Apoprotein of Folch’s 
(WM) (7) -43.9a 7.4 10.7 
(MY) (6) -36.3b 1.3 - 3.3 
proteolipid 
Myelin basic 
protein 
Myelin basic protein 
(AFP) (5) -37.8a -18.8C - 3.3 
(BP) (6) -29.8b 3.9 1.7 
plus lipids (BPL) (5) -39.9a 11.8 4.1 
a Significant at P < 0.001 
b Significant at P < 0.0 1 
’ Significant at P < 0.02 
P was calculated by Student’s t test for non-correlated samples 
Results from animals FC are mean values f SEM, the number of animals in each group is given in brackets. 
Rats were injected intradermally in each hind foot with: animals FC, 0.25 ml Freund’s complete adjuvant 
emulsified with 10% water. Animals WM, same as FC but including 35 mg homogenized bovine white matter. 
Animals My, AFP and BP, same as FC but including 4.2 mg lyophilized bovine myelin, 0.2 mg apoprotein 
Folch’s proteolipid or 0.2 mg myelin basic protein, respectively. Animals BPL, same as BP plus 0.16 mg of 
sulphatides, 0.7 mg of cerebrosides, 0.85 mg of cholesterol and 2.5 lrmoles of dipalmitoylphosphatidyl- 
choline. The preparations were sonicated for 3 min at 20 kHz in a Branson sonifier before injection. Similar 
results to those in brain were obtained in spinal cord except that total cholesterol in animals AFP was not 
significantly altered 
support to a previous interpretation [4] in which we 
suggested that the alterations of brain lipids in EAE 
may be the consequence of independent and specific 
disruptive responses directed towards some membrane 
constituents, mediated by immunological agents. 
These facts can probably be better understood at 
present in view of the recent advances in the knowl- 
edge of the dynamic structure of membranes [ 121, 
of the particular interactions occurring between lipids 
and proteins of myelin [ 131 and of the modifications 
of cell surface interactions by immunological agents 
1141. 
The alterations of the lipid content in our animals 
after the injection of purified myelin constituents 
appear to be closely related to the behaviour of 
myelin components in model membranes. Thus, the 
significant interactions between sulphatides and 
myelin basic protein or the apoprotein of Folch’s 
proteolipid described in lipid monolayers [ 151 may 
correlate to the changes we observed in the CNS 
sulphatide content of animals injected with those 
purified proteins. Similarly, the increased levels of 
esterified cholesterol and the altered CNS cholesterol 
content induced by the apoprotein of Folch’s proteo- 
lipid can be related to the preferential interactions 
between this protein and cholesterol in monolayers 
[ 151. It is possible that cellular or humoral immuno- 
logical agents originated in response to protein [ 161 
and lipid haptens [ 171 that are myelin constituents, 
known to occur in EAE animals, may modify the 
normal interactions between the membrane com- 
ponents. Surface immunoglobulins of limphoid cells 
[ 141 as well as membrane components of myelin 
[ 181 can undergo topographical rearrangements 
31 
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involving patching phenomena which seem to be a 
general mechanism leading to selective removal of 
certain membrane molecules [ 141. 
Figure 2 represents an interpretation of the results 
described in EAE. Alternative mechanisms that would 
result in selective lipid alterations are shown. One 
possibility is the concomitant removal of the target 
(Le., the basic protein) and associated component by 
a sensitized cell (fig.2,II). However, the loosening of 
normal ipid-protein associations brought about by 
removal of protein molecules (i.e., the apoprotein of 
Folch’s proteolipid) by the perturbing immunological 
agent might also lead to lipid alterations (fig.2,III). In 
the case of brain cerebroside alterations induced by 
injection of CNS lipids [4] the disturbing molecule 
could be an antibody directed against this lipid hapten 
[ 191 (fig.:!,IV). The lipid molecules thus loosened 
from specific interactions could be made available to 
enzymatic activities which, because of a changed 
environment inthe membrane, might be less restrained 
in the damaged tissue. Mechanisms of the type 
proposed would lead to quantitative alterations in 
the lipid content without requiring an independent 
activation of several enzymes in response to each of 
the different components injected. In this connection 
it is to be noted that the activity of arylsulphatase A, 
an enzyme involved in the metabolism of sulphatides, 
was not increased in the brain of animals with EAE in 
a magnitude that could be correlated to the changes 
in the content of this lipid [20] . Esterified cholesterol 
and glycosphingolipid changes imilar to those de- 
scribed in EAE occur in a variety of human demyelin- 
ating diseases [5,21] . Since cellular or humoral 
immunologicaI gents against myelin components 
occur in both EAE [ 16,171 and multiple sclerosis 
[22] , a mechanism of the type discussed above might 
also be applied to some of the human disorders. 
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